Welcome to Jennison. This page is intended for Institutional Investors. Change your role here.
You are attested as a Financial Advisor / Intermediary, but this page is intended for an Institutional Investor. Change your role here.
You are attested as a Borrower, but this page is intended for an Institutional Investor. Change your role here.
You are attested as an Individual Investor, but this page is intended for an Istitutional Investor. Change your role here.
You are attested as a Financial Advisor / Intermediary, but this page is intended for an Institutional Investor.
You are attested as a Borrower, but this page is intended for an Institutional Investor.
You are attested as an Individual Investor, but this page is intended for an Istitutional Investor.
Jennison Managing Director
Christopher Caponetti is an equity research analyst covering healthcare for small cap and healthcare strategies. Based in New York, he joined the firm in 2014.
Previously, Christopher was an associate and analyst covering specialty pharmaceutical companies at Morgan Stanley.
He received a BS, summa cum laude, in economics from Wharton School of the University of Pennsylvania. Christopher is a CFA charterholder.
PGIM appreciates your trust and respects your privacy. We use cookies to improve your experience. You can manage your cookie settings and learn more about how we protect your information at the PGIM Privacy Center .
*This website uses cookies
PGIM appreciates your trust and respects your privacy. We use cookies to improve your experience. You can manage your cookie settings and learn more about how we protect your information at the PGIM Privacy Center .
This field is required.
Loading terms...
Terms and Conditions could not be loaded. Please contact your system administrator.